Cargando…

Computational modeling of sphingolipid metabolism

BACKGROUND: As suggested by the origin of the word, sphingolipids are mysterious molecules with various roles in antagonistic cellular processes such as autophagy, apoptosis, proliferation and differentiation. Moreover, sphingolipids have recently been recognized as important messengers in cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Wronowska, Weronika, Charzyńska, Agata, Nienałtowski, Karol, Gambin, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537549/
https://www.ncbi.nlm.nih.gov/pubmed/26275400
http://dx.doi.org/10.1186/s12918-015-0176-9
_version_ 1782385905084923904
author Wronowska, Weronika
Charzyńska, Agata
Nienałtowski, Karol
Gambin, Anna
author_facet Wronowska, Weronika
Charzyńska, Agata
Nienałtowski, Karol
Gambin, Anna
author_sort Wronowska, Weronika
collection PubMed
description BACKGROUND: As suggested by the origin of the word, sphingolipids are mysterious molecules with various roles in antagonistic cellular processes such as autophagy, apoptosis, proliferation and differentiation. Moreover, sphingolipids have recently been recognized as important messengers in cellular signaling pathways. Notably, sphingolipid metabolism disorders have been observed in various pathological conditions such as cancer and neurodegeneration. RESULTS: The existing formal models of sphingolipid metabolism focus mainly on de novo ceramide synthesis or are limited to biochemical transformations of particular subspecies. Here, we propose the first comprehensive computational model of sphingolipid metabolism in human tissue. Contrary to the previous approaches, we use a model that reflects cell compartmentalization thereby highlighting the differences among individual organelles. CONCLUSIONS: The model that we present here was validated using recently proposed methods of model analysis, allowing to detect the most sensitive and experimentally non-identifiable parameters and determine the main sources of model variance. Moreover, we demonstrate the usefulness of our model in the study of molecular processes underlying Alzheimer’s disease, which are associated with sphingolipid metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0176-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4537549
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45375492015-08-16 Computational modeling of sphingolipid metabolism Wronowska, Weronika Charzyńska, Agata Nienałtowski, Karol Gambin, Anna BMC Syst Biol Research Article BACKGROUND: As suggested by the origin of the word, sphingolipids are mysterious molecules with various roles in antagonistic cellular processes such as autophagy, apoptosis, proliferation and differentiation. Moreover, sphingolipids have recently been recognized as important messengers in cellular signaling pathways. Notably, sphingolipid metabolism disorders have been observed in various pathological conditions such as cancer and neurodegeneration. RESULTS: The existing formal models of sphingolipid metabolism focus mainly on de novo ceramide synthesis or are limited to biochemical transformations of particular subspecies. Here, we propose the first comprehensive computational model of sphingolipid metabolism in human tissue. Contrary to the previous approaches, we use a model that reflects cell compartmentalization thereby highlighting the differences among individual organelles. CONCLUSIONS: The model that we present here was validated using recently proposed methods of model analysis, allowing to detect the most sensitive and experimentally non-identifiable parameters and determine the main sources of model variance. Moreover, we demonstrate the usefulness of our model in the study of molecular processes underlying Alzheimer’s disease, which are associated with sphingolipid metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0176-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-15 /pmc/articles/PMC4537549/ /pubmed/26275400 http://dx.doi.org/10.1186/s12918-015-0176-9 Text en © Wronowska et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wronowska, Weronika
Charzyńska, Agata
Nienałtowski, Karol
Gambin, Anna
Computational modeling of sphingolipid metabolism
title Computational modeling of sphingolipid metabolism
title_full Computational modeling of sphingolipid metabolism
title_fullStr Computational modeling of sphingolipid metabolism
title_full_unstemmed Computational modeling of sphingolipid metabolism
title_short Computational modeling of sphingolipid metabolism
title_sort computational modeling of sphingolipid metabolism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537549/
https://www.ncbi.nlm.nih.gov/pubmed/26275400
http://dx.doi.org/10.1186/s12918-015-0176-9
work_keys_str_mv AT wronowskaweronika computationalmodelingofsphingolipidmetabolism
AT charzynskaagata computationalmodelingofsphingolipidmetabolism
AT nienałtowskikarol computationalmodelingofsphingolipidmetabolism
AT gambinanna computationalmodelingofsphingolipidmetabolism